Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIVJoel E. Gallant, Andrew Cheng, Edwin DeJesus et al.|New England Journal of Medicine|2006Cited by 886
Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 YearsStephanos J. Hadziyannis, Steven L. Chuck, Nicolaos C. Tassopoulos et al.|Gastroenterology|2006Cited by 882
Infections with<i>Cryptococcus neoformans</i>in the Acquired Immunodeficiency SyndromeSteven L. Chuck, Merle A. Sande|New England Journal of Medicine|1989Cited by 801
Adefovir Dipivoxil for Wait-Listed and Post–Liver Transplantation Patients with Lamivudine-Resistant Hepatitis BEugene R. Schiff, Steven L. Chuck, Ching‐Lung Lai et al.|Liver Transplantation|2007Cited by 236
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority studyJean‐Michel Molina, Steven L. Chuck, Anthony LaMarca et al.|The Lancet Infectious Diseases|2011Cited by 172